Oncolytic Virus Immunotherapy Market
Oncolytic Virus Immunotherapy Market - Global Industry Assessment & Forecast
#
Pages:
147
Base Year:
2022
Sep - 2023
Format:
Report Code:
VMR-2287
Segments Covered
By
Product Type Herpes Simplex Virus, Adenovirus, Vaccinia Virus, Vesicular Stomatitis Virus, Other Product Types
-
By
Application Melanoma, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Other Applications
-
By
End User Hospitals, Specialty Clinics, Cancer Research Institutes
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 100 Million |
 Revenue 2030:
|
USD 615.39 Million |
 Revenue CAGR
(2023 - 2030): |
25.5% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Oncolytic Virus Immunotherapy Market Segment Analysis
- Oncolytic Virus Immunotherapy Product Type Outlook (Revenue, USD Million, 2018 - 2030)
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Oncolytic Virus Immunotherapy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Oncolytic Virus Immunotherapy End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
-
North America Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
-
North America Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- U.S.
- U.S. Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- U.S. Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- U.S. Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- U.S. Oncolytic Virus Immunotherapy Market, by Product Type
- Canada
- Canada Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Canada Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Canada Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Canada Oncolytic Virus Immunotherapy Market, by Product Type
-
Mexico
- Mexico Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Mexico Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Mexico Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Mexico Oncolytic Virus Immunotherapy Market, by Product Type
-
North America Oncolytic Virus Immunotherapy Market, by Product Type
- Europe
-
Europe Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
-
Europe Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
-
Europe Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- U. K.
- U.K. Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- U.K. Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- U.K. Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- U.K. Oncolytic Virus Immunotherapy Market, by Product Type
- France
- France Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- France Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- France Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- France Oncolytic Virus Immunotherapy Market, by Product Type
-
Germany
- Germany Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Germany Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Germany Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Germany Oncolytic Virus Immunotherapy Market, by Product Type
-
Italy
- Italy Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Italy Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Italy Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Italy Oncolytic Virus Immunotherapy Market, by Product Type
-
Spain
- Spain Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Spain Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Spain Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Spain Oncolytic Virus Immunotherapy Market, by Product Type
-
Rest of Europe
- Rest of Europe Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Rest of Europe Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Rest of Europe Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Rest of Europe Oncolytic Virus Immunotherapy Market, by Product Type
-
Europe Oncolytic Virus Immunotherapy Market, by Product Type
- Asia Pacific
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- China
- China Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- China Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- China Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- China Oncolytic Virus Immunotherapy Market, by Product Type
- Japan
- Japan Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Japan Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Japan Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Japan Oncolytic Virus Immunotherapy Market, by Product Type
-
Germany
- Germany Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Germany Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Germany Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Germany Oncolytic Virus Immunotherapy Market, by Product Type
-
India
- India Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- India Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- India Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- India Oncolytic Virus Immunotherapy Market, by Product Type
-
South Korea
- South Korea Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- South Korea Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- South Korea Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- South Korea Oncolytic Virus Immunotherapy Market, by Product Type
-
South East Asia
- South East Asia Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- South East Asia Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- South East Asia Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- South East Asia Oncolytic Virus Immunotherapy Market, by Product Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type
- Latin America
-
Latin America Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
-
Latin America Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
-
Latin America Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Brazil
- Brazil Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Brazil Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Brazil Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Brazil Oncolytic Virus Immunotherapy Market, by Product Type
- Argentina
- Argentina Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Argentina Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Argentina Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Argentina Oncolytic Virus Immunotherapy Market, by Product Type
-
Rest of Latin America
- Rest of Latin America Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Rest of Latin America Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Rest of Latin America Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Rest of Latin America Oncolytic Virus Immunotherapy Market, by Product Type
-
Latin America Oncolytic Virus Immunotherapy Market, by Product Type
- Middle East & Africa
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- GCC Countries
- GCC Countries Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- GCC Countries Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- GCC Countries Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- GCC Countries Oncolytic Virus Immunotherapy Market, by Product Type
- South Africa
- South Africa Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- South Africa Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- South Africa Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- South Africa Oncolytic Virus Immunotherapy Market, by Product Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, by Product Type
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Vesicular Stomatitis Virus
- Other Product Types
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, by Application
- Melanoma
- Prostate Cancer
- Ovarian Cancer
- Lung Cancer
- Breast Cancer
- Other Applications
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, by End User
- Hospitals
- Specialty Clinics
- Cancer Research Institutes
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, by Product Type
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by Product Type
- North America
Vantage Market
Research | 19-Sep-2023
FAQ
Frequently Asked Question
What is the global demand for Oncolytic Virus Immunotherapy in terms of revenue?
-
The global Oncolytic Virus Immunotherapy valued at USD 100 Million in 2022 and is expected to reach USD 615.39 Million in 2030 growing at a CAGR of 25.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Sorrento Therapeutics Inc. (U.S.), Merck & Co. Inc. (U.S.), Amgen Inc. (U.S.), Shanghai Sunway Biotech Co. Ltd. (China), Cold Genesys Inc. (U.S.), Oncolytics Biotech Inc. (Canada), Transgene Biotek Ltd. (India), SillaJen Inc. (South Korea), ORYX GmbH & Co. KG (Germany), Viralytics Ltd. (Australia).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 25.5% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Oncolytic Virus Immunotherapy include
- Rising incidences of cancer and growing cases of Genetic diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Oncolytic Virus Immunotherapy in 2022.
